Market Place
Sourcing Support
Nuance Pharma Expands Bentrio Distribution In Asia
26 Sep 2024 //
BIOSPECTRUM ASIA
Altamira Expands Bentrio Agreement With Nuance Pharma
16 Sep 2024 //
GLOBENEWSWIRE
Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
02 Apr 2024 //
FINANCIAL TIMES
Nuance Announces Dosing of First Patient in ENHANCE China Phase 3 Trial for COPD
10 Apr 2023 //
GLOBENEWSWIRE
Nuance Announces Dosing of First Patient in ENHANCE - China Phase III Trial
06 Apr 2023 //
PR NEWSWIRE
Nuance Pharma partners with DKSH to launch Bentri Nasal Spray in Hong Kong
02 Dec 2022 //
BIOSPECTRUMASIA
Chinese CDE grants IND clearance for Nuance’s RSV vaccine trial
14 Nov 2022 //
CLINICALTRIALSARENA
Nuance Pharma Announces Clearance of IND Application for Ensifentrine Trials
18 Aug 2022 //
PRNEWSWIRE
Nuance Pharma completes dosing for all NTM-001 PI study participants
26 Jul 2022 //
PRNEWSWIRE
Bavarian Nordic Deal Opens Up Potential China Market For RSV Vaccine
22 Mar 2022 //
SCRIP
Microsoft closes on $16-bn acquisition of Nuance for healthcare foray
05 Mar 2022 //
BUSINESS-STANDARD
Nuance Pharma acquires Sino Health
06 Jan 2022 //
PRNEWSWIRE
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma for RDS
22 Dec 2021 //
PRNEWSWIRE
UK Pharma invests $219M to scale up respiratory drug in China, Taiwan, HK, Macau
24 Jun 2021 //
BIOSPECTRUMASIA
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration
10 Jun 2021 //
PRNEWSWIRE
Antibe Therapeutics Announces Strategic Licensing Deal in China With Nuance
09 Feb 2021 //
BUSINESSWIRE
Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics
09 Feb 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.